Your browser is out-of-date!

Update your browser to view this website correctly.

1Cookies

2Disclaimer

With healthcare equities trading at their steepest discount to the broader market in over a decade, Bellevue Asset Management used a recent Hubbis roundtable in Hong Kong to make the case for re-engaging with the sector. Drawing on data from its May 2026 roadshow, the Swiss specialist manager outlined why depressed sentiment, robust fundamentals and an unmatched innovation pipeline may be setting the stage for a meaningful rerating.

Healthcare's valuation disconnect signals opportunity for Asia's Wealth allocators

With healthcare equities trading at their steepest discount to the broader market in over a decade, Bellevue Asset Management used a recent Hubbis roundtable in Hong Kong to make the case for re-engaging with the sector. Drawing on data from its May 2026 roadshow, the Swiss specialist manager outlined why depressed sentiment, robust fundamentals and an unmatched innovation pipeline may be setting the stage for a meaningful rerating.
05.06.2026 - Marcel Fritsch

These investment strategies might interest you